+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fluorouracil"

From
Liver Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Liver Cancer Treatment Drugs Markets in China

  • Report
  • September 2023
  • 239 Pages
  • China
From
Liver Cancer Treatment Drugs Companies in China - Product Thumbnail Image

Liver Cancer Treatment Drugs Companies in China

  • Report
  • September 2023
  • 69 Pages
  • China
From
From
From
Colon Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Colon Cancer Treatment Drugs Markets in China

  • Report
  • July 2023
  • 199 Pages
  • China
From
Colorectal Cancer Market Forecast (2020-2025) - Product Thumbnail Image

Colorectal Cancer Market Forecast (2020-2025)

  • Report
  • August 2020
  • 113 Pages
  • Global
From
Loading Indicator

Fluorouracil (5-FU) is a chemotherapy drug used in the treatment of cancer. It is a pyrimidine analog, which interferes with the synthesis of DNA and RNA, leading to cell death. It is used to treat a variety of cancers, including breast, colorectal, gastric, pancreatic, and head and neck cancers. It is also used in combination with other drugs to treat advanced or metastatic cancers. Fluorouracil is administered intravenously or topically, depending on the type of cancer being treated. Fluorouracil is a widely used drug in the oncology market, and is often used in combination with other drugs to treat advanced or metastatic cancers. It is a generic drug, and is available in both branded and generic formulations. The branded formulations are typically more expensive than the generic versions. Companies in the Fluorouracil market include Pfizer, Merck, Bristol-Myers Squibb, Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more